Penn Medicine The Intersection of Hypertension, Diabetes, and Lipids Everything You Need to Know in Preventive Cardiology in 2021
Format:13 videos + 12 pdfs, size: 4.86 GB
Course Audience: cardiologist, internist, family medicine physician
Overview:
Date & Location
Friday, October 1, 2021, 7:45 AM – 2:00 PM EST, Live, Virtual, Philadelphia, PA
Course Overview
Cardiovascular disease is the leading cause of death in the United States. Hypertension and diabetes are among the foremost risk factors for the development of cardiovascular diseases, including stroke, peripheral artery disease, and heart attack. Several advances have been made in recent years to improve our ability to prevent the development and progression of cardiovascular disease. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the use of SGLT 2 Inhibitors and GLP-1 agonists to reduce the risk of cardiovascular disease and progression of kidney disease, monitoring and management of hypertension in special patient populations, and common lipid issues in patient care.
Target Audience
Specialties – FAMILY MEDICINE, FAMILY MEDICINE – Geriatric Medicine, INTERNAL MEDICINE, INTERNAL MEDICINE – Advanced Heart Failure and Transplant Cardiology, INTERNAL MEDICINE – Clinical Cardiac Electrophysiology, INTERNAL MEDICINE – Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE – Geriatric Medicine, INTERNAL MEDICINE – Interventional Cardiology, INTERNAL MEDICINE – Nephrology, INTERNAL MEDICINE – Sports Medicine, OBSTETRICS AND GYNECOLOGY, OBSTETRICS AND GYNECOLOGY – Maternal and Fetal Medicine, PREVENTIVE MEDICINE – Clinical Informatics, PUBLIC HEALTH AND GENERAL PREVENTIVE MEDICINE
Learning Objectives
Upon successful completion of this activity, participants should be able to:
- Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations
- Identify appropriate blood pressure goals and management in several special patient populations
- Describe the controversies regarding the appropriate screening, confirmatory testing, and management of patients at risk for primary aldosteronism
- Achieve competence in providing the best screening and treatment options for hypertension in patients with hyperlipidemia
- Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention
Antiplatelet Treatment – Who Needs it. (Video MP4 Format)
Antiplatelet Treatment – Who Needs it. (PDF Format)
Brochure_71943.docx
Case Discussion with the Experts (Video MP4 Format)
Cholesterol Management During Pregnancy When to Check, and How to Manage. (Video MP4 Format)
Cholesterol Management During Pregnancy When to Check, and How to Manage. (PDF Format)
Efficacy and Outcome Studies for Renal Disease in DM and non DM (Video MP4 Format)
Efficacy and Outcome Studies for Renal Disease in DM and non DM (PDF Format)
Efficacy and Outcomes Studies for CV Protection (Video MP4 Format)
Efficacy and Outcomes Studies for CV Protection (PDF Format)
How to Prescribe SGLT2 Inhibitors – The Practicalities (Video MP4 Format)
How to Prescribe SGLT2 Inhibitors – The Practicalities (PDF Format)
Introduction and Welcome (Video MP4 Format)
Lp(a). – What Should I Know. (Video MP4 Format)
Lp(a). – What Should I Know. (PDF Format)
Management of Hypertension in CKD (Video MP4 Format)
Management of Hypertension in CKD (PDF Format)
Management of Hypertension in the Hospital Setting (Video MP4 Format)
Management of Hypertension in the Hospital Setting (PDF Format)
New Opportunities to Integrate Home BP into Telehealth (Video MP4 Format)
New Opportunities to Integrate Home BP into Telehealth (PDF Format)
Noninvasive Evaluation of CAD What Test Should I Order. (Video MP4 Format)
Noninvasive Evaluation of CAD What Test Should I Order. (PDF Format)
Primary Aldosteronism – A Continuum From Normotension to Resistant Hypertension (Video MP4 Format)
Primary Aldosteronism – A Continuum From Normotension to Resistant Hypertension (PDF Format)